SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 25 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN STANLEY | 152,000 | $256,500 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 2,000 | $3,372 | 0.00% |
| Citadel Advisors | 350,000 | $587,937 | 0.00% |
| ROYAL BANK OF CANADA | 2,000 | $3,000 | 0.00% |
| JPMORGAN CHASE & CO | 601,000 | $1,013,803 | 0.00% |
This page lists SAREPTA THERAPEUTICS INC's shareholders in Q2 2023. To view SAREPTA THERAPEUTICS INC's shareholder history, click here.